BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26880453)

  • 61. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.
    Stolina M; Dwyer D; Niu QT; Villasenor KS; Kurimoto P; Grisanti M; Han CY; Liu M; Li X; Ominsky MS; Ke HZ; Kostenuik PJ
    Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism.
    Henneicke H; Herrmann M; Kalak R; Brennan-Speranza TC; Heinevetter U; Bertollo N; Day RE; Huscher D; Buttgereit F; Dunstan CR; Seibel MJ; Zhou H
    Bone; 2011 Oct; 49(4):733-42. PubMed ID: 21722764
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The cytoskeletal regulatory scaffold protein GIT2 modulates mesenchymal stem cell differentiation and osteoblastogenesis.
    Wang X; Liao S; Nelson ER; Schmalzigaug R; Spurney RF; Guilak F; Premont RT; Gesty-Palmer D
    Biochem Biophys Res Commun; 2012 Aug; 425(2):407-12. PubMed ID: 22846567
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.
    Sugatani T; Agapova OA; Fang Y; Berman AG; Wallace JM; Malluche HH; Faugere MC; Smith W; Sung V; Hruska KA
    Kidney Int; 2017 Jan; 91(1):86-95. PubMed ID: 27666759
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mice expressing a constitutively active PTH/PTHrP receptor in osteoblasts show reduced callus size but normal callus morphology during fracture healing.
    Marsell R; Jonsson KB; Cho TJ; Einhorn TA; Ohlsson C; Schipani E
    Acta Orthop; 2007 Feb; 78(1):39-45. PubMed ID: 17453391
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH.
    Merciris D; Schiltz C; Legoupil N; Marty-Morieux C; de Vernejoul MC; Geoffroy V
    Bone; 2007 Jan; 40(1):75-83. PubMed ID: 16949899
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Whole body vibration improves osseointegration by up-regulating osteoblastic activity but down-regulating osteoblast-mediated osteoclastogenesis via ERK1/2 pathway.
    Zhou Y; Guan X; Liu T; Wang X; Yu M; Yang G; Wang H
    Bone; 2015 Feb; 71():17-24. PubMed ID: 25304090
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
    Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
    J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Notch Ligand Jagged1 Regulates the Osteoblastic Lineage by Maintaining the Osteoprogenitor Pool.
    Lawal RA; Zhou X; Batey K; Hoffman CM; Georger MA; Radtke F; Hilton MJ; Xing L; Frisch BJ; Calvi LM
    J Bone Miner Res; 2017 Jun; 32(6):1320-1331. PubMed ID: 28277610
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transgenic models of metabolic bone disease: impact of estrogen receptor deficiency on skeletal metabolism.
    McCauley LK; Tözüm TF; Kozloff KM; Koh-Paige AJ; Chen C; Demashkieh M; Cronovich H; Richard V; Keller ET; Rosol TJ; Goldstein SA
    Connect Tissue Res; 2003; 44 Suppl 1():250-63. PubMed ID: 12952206
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Osteoblastic molecular scaffold Gab1 is required for maintaining bone homeostasis.
    Weng T; Mao F; Wang Y; Sun Q; Li R; Yang G; Zhang X; Luo J; Feng GS; Yang X
    J Cell Sci; 2010 Mar; 123(Pt 5):682-9. PubMed ID: 20124419
    [TBL] [Abstract][Full Text] [Related]  

  • 72. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rictor is required for optimal bone accrual in response to anti-sclerostin therapy in the mouse.
    Sun W; Shi Y; Lee WC; Lee SY; Long F
    Bone; 2016 Apr; 85():1-8. PubMed ID: 26780446
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice.
    Xie Y; Yi L; Weng T; Huang J; Luo F; Jiang W; Xian CJ; Du X; Chen L
    Int J Biol Sci; 2016; 12(8):990-9. PubMed ID: 27489502
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Real-time monitoring of pH-dependent intracellular trafficking of ovarian cancer G protein-coupled receptor 1 in living leukocytes.
    Tan M; Yamaguchi S; Nakamura M; Nagamune T
    J Biosci Bioeng; 2018 Sep; 126(3):363-370. PubMed ID: 29655915
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cortisol inhibits acid-induced bone resorption in vitro.
    Krieger NS; Frick KK; Bushinsky DA
    J Am Soc Nephrol; 2002 Oct; 13(10):2534-9. PubMed ID: 12239242
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tail-suspended mice lacking calponin H1 experience decreased bone loss.
    Yotsumoto N; Takeoka M; Yokoyama M
    Tohoku J Exp Med; 2010 Jul; 221(3):221-7. PubMed ID: 20551601
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chemokine-like receptor 1 deficiency leads to lower bone mass in male mice.
    Zhao H; Yan D; Xiang L; Huang C; Li J; Yu X; Huang B; Wang B; Chen J; Xiao T; Ren PG; Zhang JV
    Cell Mol Life Sci; 2019 Jan; 76(2):355-367. PubMed ID: 30374519
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Coincidence Detection of Membrane Stretch and Extracellular pH by the Proton-Sensing Receptor OGR1 (GPR68).
    Wei WC; Bianchi F; Wang YK; Tang MJ; Ye H; Glitsch MD
    Curr Biol; 2018 Dec; 28(23):3815-3823.e4. PubMed ID: 30471999
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ovarian cancer G protein-coupled receptor 1 deficiency exacerbates crystal deposition and kidney injury in oxalate nephropathy in female mice.
    Yassini N; Sprenger J; Pastor Arroyo EM; Krudewig C; Pellegrini G; Joller N; Wagner CA; Imenez Silva PH
    Clin Sci (Lond); 2023 Jul; 137(14):1013-1025. PubMed ID: 37431800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.